PUNE – The Board of Directors of Emcure Pharmaceuticals Limited has approved the re-appointment of Dr. Vidya Rajiv Yeravdekar as a Non-Executive Independent Director. Her second term will commence on April 16, 2026, for a duration of five consecutive years.
Profile & Academic Leadership
-
Principal Role: Dr. Yeravdekar is the Principal Director of Symbiosis Society and the Pro-Chancellor of Symbiosis International (Deemed University).
-
Education: A highly qualified professional, she holds an M.B.B.S. and a Ph.D. in Internationalization of Higher Education in India.
-
Global Recognition: She is a prominent figure in Indian higher education, serving on various government committees, including the University Grants Commission (UGC) and the Indian Council for Cultural Relations (ICCR).
Significance for Emcure
-
Governance: Her extension ensures continuity in the Board’s oversight as Emcure continues its expansion in the global pharmaceutical market.
-
Diversity of Expertise: With her background in medicine and administration, she provides a unique perspective on human capital, compliance, and institutional growth.
-
Compliance: The re-appointment is subject to the approval of shareholders via a special resolution, as per SEBI regulations.
The move comes at a time when Emcure, led by Satish Mehta and Shark Tank India’s Namita Thapar, is focusing heavily on R&D and specialized therapeutic areas.
